Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001312065 | SCV001502500 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | VPS13D: BP4, BS2 |
Labcorp Genetics |
RCV001312065 | SCV002428241 | likely benign | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543589 | SCV003737992 | likely benign | Inborn genetic diseases | 2021-08-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003346452 | SCV004049316 | likely benign | Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001312065 | SCV005259910 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918850 | SCV004728213 | likely benign | VPS13D-related disorder | 2019-03-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |